Enzymatica strengthens its organisation

Regulatory information

The biotechnology company, Enzymatica, has made strategic recruitments to strengthen the organisation in the development of the business. The new CFO and Senior Communication Officer will provide the management team with the expertise necessary to handle major changes, including the planned and already announced switch of listing from AktieTorget to NASDAQ OMX Small Cap.

From April, the company will be reinforced by a new CFO and an expert in IR and project management, with the recruitment of:

Johan Wennerholm, CFO. Johan is currently CEO of Occlutech International AB. Johan was CFO of CellaVision AB from 2007-2012.
Tina Dackemark Lawesson, Senior Communication Officer. Tina is currently Director of Investor Relations at CellaVision AB.

“I am delighted that we have been able to strengthen our organisation through the recruitment of such highly-qualified people. Both Johan and Tina have valuable experience of working in companies which were at the same stage as Enzymatica is now,” says Michael Edelborg Christensen, CEO of Enzymatica AB.

Enzymatica has also begun the process of recruiting a Sales Director, and aims to complete this before the summer. In addition, R & D will be strengthened during the year

For more information on Enzymatica, please contact: Michael Edelborg Christensen, CEO Enzymatica AB (publ), +46 (0)768-14 41 66, michael.christensen@enzymatica.se 


Enzymatica cares about your privacy and processes your personal data in accordance with the EU’s General Data Protection Regulation. For more information about how we handle your personal information, and what rights you have, please refer to our personal data processing document here.